This STZ-ICV-induced sporadic AD model expresses progressive Aβ and p-tau overaccumulation, accompanied by neuroinflammation, decreased brain glucose utilization, neuronal loss, and cognitive impairments. The gene discussed is MAPT; the disease is Alzheimer disease.